You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 48 No. 2, February 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Frontal impairment and hypoperfusion in neuroacanthocytosis

F. Delecluse, J. Deleval, J. M. Gerard, A. Michotte and D. Zegers de Beyl
Neurology Service, Erasme Hospital, University of Brussels, Belgium.

Cerebral blood flow tomography, by xenon 133 inhalation or HMPAO (99mTc-d, l-hexamethyl-propylene amine oxime) technetium Tc 99m injection, revealed a severe hypoperfusion in both frontal lobes of a 40-year-old woman with confirmed neuroacanthocytosis. This finding occurred in conjunction with neuropsychological deficits consistent with selective frontal lobe dysfunction. This observation is the first documentation of this type of dementia in neuroacanthocytosis.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Schizophrenia-Like Presentation of Neuroacanthocytosis
Bruneau et al.
J. Neuropsychiatry Clin. Neurosi. 2003;15:378-380.
ABSTRACT | FULL TEXT  

Reduction of striatal glucose metabolism in McLeod choreoacanthocytosis
Oechsner et al.
J. Neurol. Neurosurg. Psychiatry 2001;70:517-520.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.